Russian CTEPH registry aims to uncover key prognosis factors
NCT ID NCT07254078
First seen Dec 16, 2025 · Last updated May 24, 2026 · Updated 20 times
Summary
This study is collecting information from 500 people in Russia who have chronic thromboembolic pulmonary hypertension (CTEPH), a serious lung condition. Researchers want to see which factors—like medical history, symptoms, and treatments—most affect long-term survival and health. The study does not test any new treatment, but observes real-world care to improve future outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Medical Research Center of Cardiology after academician E.I. Chazov
RECRUITINGMoscow, Russia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.